Drawing for ASTEX

USPTO serial 85293400

ASTEX

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
OH, WON TEAK
Law office
TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ASTEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Harold Milstein

HAROLD MILSTEIN SHEPPARD MULLIN RICHTER & HAMPTON LLP390 LYTTON AVEPALO ALTO, CA 94301-1432UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Research and development services in the field of pharmaceuticals; providing medical and scientific health care research information in the field of pharmaceuticals and clinical trialsACTIVE—
044Providing health care information via telephone and the internet; providing information in the field of the diagnostic, prophylactic, and therapeutic properties of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2011MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Oct 5, 2011ABN1ABANDONMENT - EXPRESS MAILED—
Oct 4, 2011EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jul 8, 2011GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 8, 2011GNSLLETTER OF SUSPENSION E-MAILED—
Jul 8, 2011CNSLSUSPENSION LETTER WRITTEN—
Jul 6, 2011DOCKASSIGNED TO EXAMINER—
Apr 17, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 15, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance